⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
globenewswire.com
MYGN
Form 8-K
sec.gov
MYGN
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
globenewswire.com
LH
MYGN
Global PARP Inhibitor Biomarkers Market Size, Share, Growth, Trends, and Forecast, 2026 to 2034 | Precision Oncology and HRD Testing Fuel 8.6% CAGR
globenewswire.com
A
BIIB
ILMN
LH
SWX
TMO
MYGN
QGEN
NEO
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
globenewswire.com
MYGN
Form 8-K
sec.gov
MYGN
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
globenewswire.com
MYGN
SOPH
AZN
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
prnewswire.com
SOPH
AZN
MYGN
PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
globenewswire.com
TMO
AGNC
QGEN
EXAS
LH
DGX
BNTX
CRSP
REGN
GILD
AMGN
BMY
MRK
PFE
ABBV
LLY
AZN
SNY
NVS
BIIB
VRTX
BMRN
IDXX
CRWD
DDOG
SNOW
NVDA
AMD
INTC
MSFT
QDEL
MYGN
SENS
INM
PRPO
CODX
BFC
BSY
NCL
ABT
DHR
BDX
BIO
BRKR
CTAS
CUE
HOLX
Europe Biopsy Devices Market Analysis, Size, Share, and Forecast 2026-2034 | Market to Reach US$1.20 Billion, Driven by Early Cancer Detection and Image-Guided Innovation
globenewswire.com
BDX
TMO
BIO
EXAS
MYGN
QGEN
NEO
DGX